Skye bioscience to present at td cowen health care conference

San diego, calif., feb. 20, 2025 (globe newswire) -- skye bioscience, inc. (nasdaq: skye) (“skye”), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, today announced that punit dhillon, chief executive officer, will present a corporate overview and be available for 1x1 meetings at the td cowen 45th annual health care conference.
COWN Ratings Summary
COWN Quant Ranking